Postoperative Application of Dexmedetomidine is the Optimal Strategy to Reduce the Incidence of Postoperative Delirium After Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials
Restricted accessResearch articleFirst published online March, 2023
Postoperative Application of Dexmedetomidine is the Optimal Strategy to Reduce the Incidence of Postoperative Delirium After Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials
Previous pairwise meta-analyses demonstrated the efficacy and safety of dexmedetomidine in preventing postoperative delirium (POD) after cardiac surgery; however, the optimal time of applying dexmedetomidine remains unclear.
Objective:
This network meta-analysis aimed to determine the optimal time of using dexmedetomidine to reduce the incidence of POD following cardiac surgery.
Methods:
We first retrieved eligible randomized controlled trials (RCTs) from previous meta-analyses, and then an updated search was performed to identify additional RCTs in PubMed, Embase, and the Cochrane library from January 1, 2021 to October 31, 2021. Two authors screened literature, collected data, and evaluated bias risk of eligible studies. Finally, we performed Bayesian network analysis using R version 3.6.1 with the “gemtc” and “rjags” package.
Results:
Eighteen studies with 2636 patients were included, and all studies were identified from previous meta-analyses. Results showed that postoperative dexmedetomidine reduced the risk of POD compared with normal saline (NS) (odds ratio [OR], 0.13; 95% credible interval [CrI], 0.03-0.35) and propofol (PRO) (OR, 0.19; 95%CrI, 0.04-0.66). Postoperative dexmedetomidine was associated with a lower incidence of POD compared with perioperative dexmedetomidine (OR, 0.21; 95% CrI, 0.04-0.82). Moreover, postoperative dexmedetomidine had the highest probability of ranking best (90.98%), followed by intraoperative dexmedetomidine (46.83%), PRO (36.94%), perioperative dexmedetomidine (30.85%), and NS (60.02%).
Conclusion and Relevance:
Dexmedetomidine reduces the incidence of POD compared with PRO and NS in patients undergoing cardiac surgery, and postoperative application of dexmedetomidine is the optimal time.
RudigerABegdedaHBabicD, et al. Intra-operative events during cardiac surgery are risk factors for the development of delirium in the ICU. Crit Care. 2016;20:264. doi:10.1186/s13054-016-1445-8.
2.
CropseyCKennedyJHanJPandharipandeP. Cognitive dysfunction, delirium, and stroke in cardiac surgery patients. Semin Cardiothorac Vasc Anesth. 2015;19(4):309-317. doi:10.1177/1089253215570062.
HasanTFKelleyRECornettEMUrmanRDKayeAD. Cognitive impairment assessment and interventions to optimize surgical patient outcomes. Best Pract Res Clin Anaesthesiol. 2020;34(2):225-253. doi:10.1016/j.bpa.2020.05.005.
5.
IndjaBSecoMSeamarkR, et al. Neurocognitive and psychiatric issues post cardiac surgery. Heart Lung Circ. 2017;26(8):779-785. doi:10.1016/j.hlc.2016.12.010.
6.
JiFLiZNguyenH, et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013;127(15):1576-1584. doi:10.1161/circulationaha.112.000936.
7.
KehletH. Enhanced postoperative recovery: good from afar, but far from good?Anaesthesia. 2020;75(suppl 1):E54-E61. doi:10.1111/anae.14860.
8.
ScicutellaA. The pharmacotherapeutic management of postoperative delirium: an expert update. Expert Opin Pharmacother. 2020;21(8):905-916. doi:10.1080/14656566.2020.1738388.
9.
BrockL. Dexmedetomidine in adult patients in cardiac surgery critical care: an evidence-based review. AACN Adv Crit Care. 2019;30(3):259-268. doi:10.4037/aacnacc2019888.
PieriMDe SimoneARoseS, et al. Trials focusing on prevention and treatment of delirium after cardiac surgery: a systematic review of randomized evidence. J Cardiothorac Vasc Anesth. 2020;34(6):1641-1654. doi:10.1053/j.jvca.2019.09.028.
12.
DuanXCoburnMRossaintRSandersRDWaesbergheJVKowarkA. Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials. Br J Anaesth. 2018;121(2):384-397. doi:10.1016/j.bja.2018.04.046.
13.
WuMLiangYDaiZWangS. Perioperative dexmedetomidine reduces delirium after cardiac surgery: a meta-analysis of randomized controlled trials. J Clin Anesth. 2018;50:33-42. doi:10.1016/j.jclinane.2018.06.045.
14.
LiPLiLXZhaoZZ, et al. Dexmedetomidine reduces the incidence of postoperative delirium after cardiac surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2021;21(1):153. doi:10.1186/s12871-021-01370-1.
15.
XiongXChenDShiJ. Is perioperative dexmedetomidine associated with a reduced risk of perioperative neurocognitive disorders following cardiac surgery? A systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Front Med (Lausanne). 2021;8:645975. doi:10.3389/fmed.2021.645975.
16.
DerSimonianRLairdN. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. doi:10.1016/0197-2456(86)90046-2.
17.
MbuagbawLRochwergBJaeschkeR, et al. Approaches to interpreting and choosing the best treatments in network meta-analyses. Syst Rev. 2017;6(1):79. doi:10.1186/s13643-017-0473-z.
18.
PageMJMoherDBossuytPM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi:10.1136/bmj.n160.
19.
HuttonBSalantiGCaldwellDM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777-784. doi:10.7326/m14-2385.
20.
HigginsJPTGreenS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Accessed June 11, 2022. https://training.cochrane.org/handbook.
21.
HigginsJPAltmanDGGotzschePC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928.
22.
MaddenLVPiephoHPPaulPA. Statistical models and methods for network meta-analysis. Phytopathology. 2016;106(8):792-806. doi:10.1094/PHYTO-12-15-0342-RVW.
23.
Palma PérezSDelgado RodríguezM. [Practical considerations on detection of publication bias]Consideraciones practicas acerca de la deteccion del sesgo de publicacion. Gac Sanit. 2006;20(suppl 3):10-16. doi:10.1157/13101085.
24.
KantersS. Fixed- and random-effects models. Methods Mol Biol. 2022;2345:41-65. doi:10.1007/978-1-0716-1566-9_3.
25.
CiprianiAHigginsJPTGeddesJRSalantiG. Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013;159(2):130-137. doi:10.7326/0003-4819-159-2-201307160-00008.
26.
ThomHWhiteIRWeltonNJLuG. Automated methods to test connectedness and quantify indirectness of evidence in network meta-analysis. Res Synth Methods. 2019;10(1):113-124. doi:10.1002/jrsm.1329.
27.
BrooksSGelmanA. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998;7:434-455. doi:10.1080/10618600.1998.10474787.
28.
BurgerDASchallR. A Bayesian nonlinear mixed-effects regression model for the characterization of early bactericidal activity of tuberculosis drugs. J Biopharm Stat. 2015;25(6):1247-1271. doi:10.1080/10543406.2014.971170.
29.
RoeverLBiondi-ZoccaiG. Network meta-analysis to synthesize evidence for decision making in cardiovascular research. Arq Bras Cardiol. 2016;106(4):333-337. doi:10.5935/abc.20160052.
30.
MavridisDGiannatsiMCiprianiASalantiG. A primer on network meta-analysis with emphasis on mental health. Evid Based Ment Health. 2015;18(2):40-46. doi:10.1136/eb-2015-102088.
31.
VeronikiAAVasiliadisHSHigginsJPSalantiG. Evaluation of inconsistency in networks of interventions. Int J Epidemiol. 2013;42(1):332-345. doi:10.1093/ije/dys222.
32.
ShimSRKimSJLeeJRückerG. Network meta-analysis: application and practice using R software. Epidemiol Health. 2019;41:e2019013. doi:10.4178/epih.e2019013.
33.
NeupaneBRicherDBonnerAJKibretTBeyeneJ. Network meta-analysis using R: a review of currently available automated packages. PLoS One. 2014;9(12):e115065. doi:10.1371/journal.pone.0115065.
34.
HigginsJPThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. doi:10.1002/sim.1186.
DiasSSuttonAJWeltonNJAdesAE. Evidence synthesis for decision making 3: heterogeneity—subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making. 2013;33(5):618-640. doi:10.1177/0272989X13485157.
37.
SalantiGAdesAEIoannidisJP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163-171. doi:10.1016/j.jclinepi.2010.03.016.
38.
BalkanayOOGoksedefDOmerogluSNIpekG. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg. 2015;20(2):209-214. doi:10.1093/icvts/ivu367.
39.
CorbettSMRebuckJAGreeneCM, et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med. 2005;33(5):940-945. doi:10.1097/01.ccm.0000162565.18193.e5.
40.
DjaianiGSilvertonNFedorkoL, et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology. 2016;124(2):362-368. doi:10.1097/ALN.0000000000000951.
41.
EremenkoAAChemovaEV. Comparison of dexmedetomidine and propofol for short-term sedation in early postoperative period after cardiac surgery. Anesteziol Reanimatol. 2014(2):37-41.
42.
GaoYZhuXHuangLTengJLiF. Effects of dexmedetomidine on cerebral oxygen saturation and postoperative cognitive function in elderly patients undergoing minimally invasive coronary artery bypass surgery. Clin Hemorheol Microcirc. 2020;74(4):383-389. doi:10.3233/CH-190590.
43.
GongZLiJZhongYGuanXHuangAMaL. Effects of dexmedetomidine on postoperative cognitive function in patients undergoing coronary artery bypass grafting. Exp Ther Med. 2018;16(6):4685-4689. doi:10.3892/etm.2018.6778.
44.
LiXYangJNieXL, et al. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PLoS One. 2017;12(2):e0170757. doi:10.1371/journal.pone.0170757.
45.
LiZLChenGZhangX. Observation of the clinical effect comparison between dexmedetomidine and propofol treated on patients with delirium after cardiac surgery. Int J Psychiatry. 2016;43(5):882-884.
46.
LikhvantsevVVLandoniGGrebenchikovOA, et al. Perioperative dexmedetomidine supplement decreases delirium incidence after adult cardiac surgery: a randomized, double-blind, controlled study. J Cardiothorac Vasc Anesth. 2021;35(2):449-457. doi:10.1053/j.jvca.2020.02.035.
47.
LiuXZhangKWangW, et al. Dexmedetomidine versus propofol sedation improves sublingual microcirculation after cardiac surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2016;30(6):1509-1515. doi:10.1053/j.jvca.2016.05.038.
48.
MassoumiGMansouriMKhamesipourS. Comparison of the incidence and severity of delirium and biochemical factors after coronary artery bypass grafting with dexmedetomidine: a randomized double-blind placebo-controlled clinical trial study. ARYA Atheroscler. 2019;15(1):14-21. doi:10.22122/arya.v15i1.1748.
49.
PriyeSJagannathSSinghDShivaprakashSReddyDP. Dexmedetomidine as an adjunct in postoperative analgesia following cardiac surgery: a randomized, double-blind study. Saudi J Anaesth. 2015;9(4):353-358. doi:10.4103/1658-354X.154715.
50.
SheikhTADarBAAkhterNAhmadN. A comparative study evaluating effects of intravenous sedation by dexmedetomidine and propofol on patient hemodynamics and postoperative outcomes in cardiac surgery. Anesth Essays Res. 2018;12(2):555-560. doi:10.4103/aer.AER_46_18.
51.
ShiCJinJQiaoLLiTMaJMaZ. Effect of perioperative administration of dexmedetomidine on delirium after cardiac surgery in elderly patients: a double-blinded, multi-center, randomized study. Clin Interv Aging. 2019;14:571-575. doi:10.2147/cia.S194476.
52.
ShuALiuXWangQChenXZhanL. Study on cerebral protective effect of dexmedetomidine during anesthesia in cardiac valve replacement surgery. Int J Clin Exp Med. 2017;10:1066-1072.
53.
SubramaniamBShankarPShaefiS, et al. Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery: the DEXACET randomized clinical trial. JAMA. 2019;321(7):686-696. doi:10.1001/jama.2019.0234.
54.
TuranADuncanALeungS, et al. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. Lancet. 2020;396(10245):177-185. doi:10.1016/s0140-6736(20)30631-0.
55.
ZhouMLyuYZhuY, et al. Effect of ulinastatin combined with dexmedetomidine on postoperative cognitive dysfunction in patients who underwent cardiac surgery. Front Neurol. 2019;10:1293. doi:10.3389/fneur.2019.01293.
56.
DeinerSLuoXLinHM, et al. Intraoperative infusion of dexmedetomidine for prevention of postoperative delirium and cognitive dysfunction in elderly patients undergoing major elective noncardiac surgery: a randomized clinical trial. JAMA Surg. 2017;152(8):e171505. doi:10.1001/jamasurg.2017.1505.
57.
MaldonadoJRWysongAvan der StarrePJBlockTMillerCReitzBA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50(3):206-217. doi:10.1176/appi.psy.50.3.206.
58.
MaheshwariAMcCormickPJSesslerDI, et al. Prolonged concurrent hypotension and low bispectral index (“double low”) are associated with mortality, serious complications, and prolonged hospitalization after cardiac surgery. Br J Anaesth. 2017;119(1):40-49. doi:10.1093/bja/aex095.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
